Presym Inc.
This article was originally published in Start Up
Executive Summary
Although roughly 80% of all heart disease is attributable to mechanical defects, the medical community relies on ultrasound imaging and other electrical/impedance methods to diagnose heart diseases. While these techniques are valuable for detecting arrhythmias and other electrical disturbances, they are unable to identify biomechanical issues that may develop into serious problems. Presym Inc. is working on a new noninvasive device that uses the trachea as a point of measurement to record all mechanical features of the heart and thus detect diseases before symptoms occur.
You may also be interested in...
Start-Up Previews (03/2010)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Transdermal Drug Delivery: More Than Skin Deep, features profiles of AllTranz, Ocelus, Quinnova and Syntropharma. Plus these Start-Ups Across Health Care: Apnex Medical, Cellular Dynamics, Helix Therapeutics, Presym and Vatrix Medical.
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.